50 related articles for article (PubMed ID: 32452658)
1. A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics.
Bult JAA; Huisman F; Zhong Y; Veltmaat N; Kluiver J; Tonino SH; Vermaat JSP; Chamuleau MED; Diepstra A; van den Berg A; Plattel WJ; Brink M; Nijland M
Blood Cancer J; 2023 Sep; 13(1):130. PubMed ID: 37658062
[TBL] [Abstract][Full Text] [Related]
2. Multiloculated Cavitary Primary Pulmonary Hodgkin Lymphoma: Case Series.
Aljehani Y; Al-Saif H; Al-Osail A; Al-Osail E
Case Rep Oncol; 2018; 11(1):90-97. PubMed ID: 29606947
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of frontline
Lossos IS; Reis IM; Rosenblatt JD; Alderuccio JP
Leuk Lymphoma; 2020 Dec; 61(13):3234-3238. PubMed ID: 32755329
[No Abstract] [Full Text] [Related]
4. Predicting DNA methylation from genetic data lacking racial diversity using shared classified random effects.
Rao JS; Zhang H; Kobetz E; Aldrich MC; Conway D
Genomics; 2021 Jan; 113(1 Pt 2):1018-1028. PubMed ID: 33161089
[TBL] [Abstract][Full Text] [Related]
5. Impact of Genetic Ancestry on Prognostic Biomarkers in Uveal Melanoma.
Rodriguez DA; Sanchez MI; Decatur CL; Correa ZM; Martin ER; Harbour JW
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33142712
[TBL] [Abstract][Full Text] [Related]
6. A How-to Guide to Building a Robust SARS-CoV-2 Testing Program at a University-Based Health System.
Nimer SD; Chapman J; Reidy L; Alencar A; Wu Y; Williams S; Pagan L; Gjolaj L; MacIntyre J; Triana M; Vance B; Andrews D; Fan YS; Zhou Y; Martinez O; Garcia-Buitrago M; Cray C; Tekin M; McCauley JL; Ruiz P; Pagan P; Lamar W; Alencar M; Bilbao D; Prieto S; Polania M; Suarez M; Lujardo M; Campos G; Morris M; Shukla B; Caban-Martinez A; Kobetz E; Parekh DJ; Jorda M
Acad Pathol; 2020; 7():2374289520958200. PubMed ID: 33088910
[TBL] [Abstract][Full Text] [Related]
7. Survival analysis in treated plasmablastic lymphoma patients: a population-based study.
Florindez JA; Alderuccio JP; Reis IM; Lossos IS
Am J Hematol; 2020 Nov; 95(11):1344-1351. PubMed ID: 32777103
[TBL] [Abstract][Full Text] [Related]
8. Splenic marginal zone lymphoma: A US population-based survival analysis (1999-2016).
Florindez JA; Alderuccio JP; Reis IM; Lossos IS
Cancer; 2020 Nov; 126(21):4706-4716. PubMed ID: 32767702
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics and prognostic factors of primary pulmonary lymphoma.
He H; Tan F; Xue Q; Liu L; Peng Y; Bai G; Zhang M; Gao S
J Thorac Dis; 2021 Feb; 13(2):1106-1117. PubMed ID: 33717584
[TBL] [Abstract][Full Text] [Related]
10. Radiological and pathological analysis of the galaxy sign in patients with pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma.
Song Y; Sung YE; Beck KS; Chang S; Jung JI; Park GS
Thorac Cancer; 2023 Aug; 14(24):2459-2466. PubMed ID: 37409441
[TBL] [Abstract][Full Text] [Related]
11. Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma.
Alderuccio JP; Lossos IS
Expert Rev Hematol; 2023 May; 16(5):333-348. PubMed ID: 37086394
[TBL] [Abstract][Full Text] [Related]
12. Management of marginal zone lymphomas.
Merli M; Arcaini L
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):676-687. PubMed ID: 36485086
[TBL] [Abstract][Full Text] [Related]
13. FDG PET/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma.
Vaxman I; Bernstine H; Kleinstern G; Hendin N; Shimony S; Domachevsky L; Gurion R; Groshar D; Raanani P; Gafter-Gvili A
Hematol Oncol; 2019 Apr; 37(2):168-175. PubMed ID: 30734341
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients.
Elsayad K; Reinartz G; Oertel M; Rehn S; Eismann J; Scobioala S; Berssenbrügge H; Eter N; Weishaupt C; Schmidt HH; Friedrichs B; Grünewald I; Hartmann W; Lenz G; Wardelmann E; Willich N; Eich HT
Strahlenther Onkol; 2020 Feb; 196(2):117-125. PubMed ID: 31732783
[TBL] [Abstract][Full Text] [Related]
15. Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era.
Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJ; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
Br J Haematol; 2016 Oct; 175(2):275-280. PubMed ID: 27443247
[TBL] [Abstract][Full Text] [Related]
16. Marginal Zone Lymphoma: State-of-the-Art Treatment.
Sindel A; Al-Juhaishi T; Yazbeck V
Curr Treat Options Oncol; 2019 Dec; 20(12):90. PubMed ID: 31807935
[TBL] [Abstract][Full Text] [Related]
17. [Marginal zone lymphoma with monoclonal immunoglobulin: three cases report and literatures review].
Wang F; Han X; Bai B; Wang C; Chen Y
Zhonghua Xue Ye Xue Za Zhi; 2016 Jan; 37(1):39-44. PubMed ID: 26876252
[TBL] [Abstract][Full Text] [Related]
18. Clinical and radiological characteristics of patients with pulmonary marginal zone lymphoma: A single center analysis.
Husnain M; Kuker R; Reis IM; Iyer SG; Zhao W; Chapman JR; Vega F; Lossos IS; Alderuccio JP
Cancer Med; 2020 Jul; 9(14):5051-5064. PubMed ID: 32452658
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
